Abstract
Recent genome-wide association studies identified 11 single nucleotide polymorphisms (SNPs) associated with breast cancer (BC) risk. We investigated these and 62 other SNPs for their prognostic relevance. Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), rs3817198 (LSP1), rs889312 (MAP3K1), rs3803662 (TOX3), rs13387042 (2q35), rs4973768 (SLC4A7), rs6504950 (COX11) and rs10941679 (5p12) were genotyped for 25 853 BC patients with the available follow-up; 62 other SNPs, which have been suggested as BC risk SNPs by a GWAS or as candidate SNPs from individual studies, were genotyped for replication purposes in subsets of these patients. Cox proportional hazard models were used to test the association of these SNPs with overall survival (OS) and BC-specific survival (BCS). For the confirmed loci, we performed an accessory analysis of publicly available gene expression data and the prognosis in a different patient group. One of the 11 SNPs, rs3803662 (TOX3) and none of the 62 candidate/GWAS SNPs were associated with OS and/or BCS at P<0.01. The genotypic-specific survival for rs3803662 suggested a recessive mode of action [hazard ratio (HR) of rare homozygous carriers=1.21; 95% CI: 1.09-1.35, P=0.0002 and HR=1.29; 95% CI: 1.12-1.47, P=0.0003 for OS and BCS, respectively]. This association was seen similarly in all analyzed tumor subgroups defined by nodal status, tumor size, grade and estrogen receptor. Breast tumor expression of these genes was not associated with prognosis. With the exception of rs3803662 (TOX3), there was no evidence that any of the SNPs associated with BC susceptibility were associated with the BC survival. Survival may be influenced by a distinct set of germline variants from those influencing susceptibility.
Original language | English |
---|---|
Article number | dds159 |
Pages (from-to) | 3926-3939 |
Number of pages | 14 |
Journal | Human Molecular Genetics |
Volume | 21 |
Issue number | 17 |
DOIs | |
Publication status | Published - Sep 2012 |
Externally published | Yes |
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
The role of genetic breast cancer susceptibility variants as prognostic factors. / Fasching, Peter A.; Pharoah, Paul D P; Cox, Angela; Nevanlinna, Heli; Bojesen, Stig E; Karn, Thomas; Broeks, Annegien; van Leeuwen, Flora E; Van't Veer, Laura J.; Udo, Renate; Dunning, Alison M; Greco, Dario; Aittomäki, Kristiina; Blomqvist, Carl; Shah, Mitul; Nordestgaard, Børge G.; Flyger, Henrik; Hopper, John L.; Southey, Melissa C.; Apicella, Carmel; Garcia-Closas, Montserrat; Sherman, Mark E; Lissowska, Jolanta; Seynaeve, Caroline; Huijts, Petra E.A.; Tollenaar, Rob A.E.M.; Ziogas, Argyrios; Ekici, Arif B; Rauh, Claudia; Mannermaa, Arto; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.; Andrulis, Irene L; Ozcelik, Hilmi; Mulligan, Anna Marie; Glendon, Gord; Hall, Per; Czene, Kamila; Liu, Jianjun; Chang-Claude, Jenny; Wang-Gohrke, Shan; Eilber, Ursula; Nickels, Stefan; Dörk, Thilo; Schiekel, Maria; Bremer, Michael; Park-Simon, Tjoung-Won; Giles, Graham G.; Severi, Gianluca; Baglietto, Laura; Hooning, Maartje J; Martens, John W M; Jager, Agnes; Kriege, Mieke; Lindblom, Annika; Margolin, Sara; Couch, Fergus J; Stevens, Kristen N.; Olson, Janet E; Kosel, Matthew; Cross, Simon S; Balasubramanian, Sabapathy P; Reed, Malcolm W R; Miron, Alexander; John, Esther M.; Winqvist, Robert; Pylkäs, Katri; Jukkola-Vuorinen, Arja; Kauppila, Saila; Burwinkel, Barbara; Marme, Frederik; Schneeweiss, Andreas; Sohn, Christof; Chenevix-Trench, Georgia; Lambrechts, Diether; Dieudonne, Anne Sophie; Hatse, Sigrid; Van Limbergen, Erik; Benitez, Javier; Milne, Roger L; Zamora, Pilar M.; Pérez, José Ignacio Arias; Bonanni, Bernardo; Peissel, Bernard; Loris, Bernard; Peterlongo, Paolo; Rajaraman, Preetha; Schonfeld, Sara J.; Anton-Culver, Hoda; Devilee, Peter; Beckmann, Matthias W.; Slamon, Dennis J; Phillips, Kelly Anne; Figueroa, Jonine D; Humphreys, Manjeet K.; Easton, Douglas F; Schmidt, Marjanka K.
In: Human Molecular Genetics, Vol. 21, No. 17, dds159, 09.2012, p. 3926-3939.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - The role of genetic breast cancer susceptibility variants as prognostic factors
AU - Fasching, Peter A.
AU - Pharoah, Paul D P
AU - Cox, Angela
AU - Nevanlinna, Heli
AU - Bojesen, Stig E
AU - Karn, Thomas
AU - Broeks, Annegien
AU - van Leeuwen, Flora E
AU - Van't Veer, Laura J.
AU - Udo, Renate
AU - Dunning, Alison M
AU - Greco, Dario
AU - Aittomäki, Kristiina
AU - Blomqvist, Carl
AU - Shah, Mitul
AU - Nordestgaard, Børge G.
AU - Flyger, Henrik
AU - Hopper, John L.
AU - Southey, Melissa C.
AU - Apicella, Carmel
AU - Garcia-Closas, Montserrat
AU - Sherman, Mark E
AU - Lissowska, Jolanta
AU - Seynaeve, Caroline
AU - Huijts, Petra E.A.
AU - Tollenaar, Rob A.E.M.
AU - Ziogas, Argyrios
AU - Ekici, Arif B
AU - Rauh, Claudia
AU - Mannermaa, Arto
AU - Kataja, Vesa
AU - Kosma, Veli-Matti
AU - Hartikainen, Jaana M.
AU - Andrulis, Irene L
AU - Ozcelik, Hilmi
AU - Mulligan, Anna Marie
AU - Glendon, Gord
AU - Hall, Per
AU - Czene, Kamila
AU - Liu, Jianjun
AU - Chang-Claude, Jenny
AU - Wang-Gohrke, Shan
AU - Eilber, Ursula
AU - Nickels, Stefan
AU - Dörk, Thilo
AU - Schiekel, Maria
AU - Bremer, Michael
AU - Park-Simon, Tjoung-Won
AU - Giles, Graham G.
AU - Severi, Gianluca
AU - Baglietto, Laura
AU - Hooning, Maartje J
AU - Martens, John W M
AU - Jager, Agnes
AU - Kriege, Mieke
AU - Lindblom, Annika
AU - Margolin, Sara
AU - Couch, Fergus J
AU - Stevens, Kristen N.
AU - Olson, Janet E
AU - Kosel, Matthew
AU - Cross, Simon S
AU - Balasubramanian, Sabapathy P
AU - Reed, Malcolm W R
AU - Miron, Alexander
AU - John, Esther M.
AU - Winqvist, Robert
AU - Pylkäs, Katri
AU - Jukkola-Vuorinen, Arja
AU - Kauppila, Saila
AU - Burwinkel, Barbara
AU - Marme, Frederik
AU - Schneeweiss, Andreas
AU - Sohn, Christof
AU - Chenevix-Trench, Georgia
AU - Lambrechts, Diether
AU - Dieudonne, Anne Sophie
AU - Hatse, Sigrid
AU - Van Limbergen, Erik
AU - Benitez, Javier
AU - Milne, Roger L
AU - Zamora, Pilar M.
AU - Pérez, José Ignacio Arias
AU - Bonanni, Bernardo
AU - Peissel, Bernard
AU - Loris, Bernard
AU - Peterlongo, Paolo
AU - Rajaraman, Preetha
AU - Schonfeld, Sara J.
AU - Anton-Culver, Hoda
AU - Devilee, Peter
AU - Beckmann, Matthias W.
AU - Slamon, Dennis J
AU - Phillips, Kelly Anne
AU - Figueroa, Jonine D
AU - Humphreys, Manjeet K.
AU - Easton, Douglas F
AU - Schmidt, Marjanka K.
PY - 2012/9
Y1 - 2012/9
N2 - Recent genome-wide association studies identified 11 single nucleotide polymorphisms (SNPs) associated with breast cancer (BC) risk. We investigated these and 62 other SNPs for their prognostic relevance. Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), rs3817198 (LSP1), rs889312 (MAP3K1), rs3803662 (TOX3), rs13387042 (2q35), rs4973768 (SLC4A7), rs6504950 (COX11) and rs10941679 (5p12) were genotyped for 25 853 BC patients with the available follow-up; 62 other SNPs, which have been suggested as BC risk SNPs by a GWAS or as candidate SNPs from individual studies, were genotyped for replication purposes in subsets of these patients. Cox proportional hazard models were used to test the association of these SNPs with overall survival (OS) and BC-specific survival (BCS). For the confirmed loci, we performed an accessory analysis of publicly available gene expression data and the prognosis in a different patient group. One of the 11 SNPs, rs3803662 (TOX3) and none of the 62 candidate/GWAS SNPs were associated with OS and/or BCS at P<0.01. The genotypic-specific survival for rs3803662 suggested a recessive mode of action [hazard ratio (HR) of rare homozygous carriers=1.21; 95% CI: 1.09-1.35, P=0.0002 and HR=1.29; 95% CI: 1.12-1.47, P=0.0003 for OS and BCS, respectively]. This association was seen similarly in all analyzed tumor subgroups defined by nodal status, tumor size, grade and estrogen receptor. Breast tumor expression of these genes was not associated with prognosis. With the exception of rs3803662 (TOX3), there was no evidence that any of the SNPs associated with BC susceptibility were associated with the BC survival. Survival may be influenced by a distinct set of germline variants from those influencing susceptibility.
AB - Recent genome-wide association studies identified 11 single nucleotide polymorphisms (SNPs) associated with breast cancer (BC) risk. We investigated these and 62 other SNPs for their prognostic relevance. Confirmed BC risk SNPs rs17468277 (CASP8), rs1982073 (TGFB1), rs2981582 (FGFR2), rs13281615 (8q24), rs3817198 (LSP1), rs889312 (MAP3K1), rs3803662 (TOX3), rs13387042 (2q35), rs4973768 (SLC4A7), rs6504950 (COX11) and rs10941679 (5p12) were genotyped for 25 853 BC patients with the available follow-up; 62 other SNPs, which have been suggested as BC risk SNPs by a GWAS or as candidate SNPs from individual studies, were genotyped for replication purposes in subsets of these patients. Cox proportional hazard models were used to test the association of these SNPs with overall survival (OS) and BC-specific survival (BCS). For the confirmed loci, we performed an accessory analysis of publicly available gene expression data and the prognosis in a different patient group. One of the 11 SNPs, rs3803662 (TOX3) and none of the 62 candidate/GWAS SNPs were associated with OS and/or BCS at P<0.01. The genotypic-specific survival for rs3803662 suggested a recessive mode of action [hazard ratio (HR) of rare homozygous carriers=1.21; 95% CI: 1.09-1.35, P=0.0002 and HR=1.29; 95% CI: 1.12-1.47, P=0.0003 for OS and BCS, respectively]. This association was seen similarly in all analyzed tumor subgroups defined by nodal status, tumor size, grade and estrogen receptor. Breast tumor expression of these genes was not associated with prognosis. With the exception of rs3803662 (TOX3), there was no evidence that any of the SNPs associated with BC susceptibility were associated with the BC survival. Survival may be influenced by a distinct set of germline variants from those influencing susceptibility.
UR - http://www.scopus.com/inward/record.url?scp=84865065666&partnerID=8YFLogxK
U2 - 10.1093/hmg/dds159
DO - 10.1093/hmg/dds159
M3 - Article
C2 - 22532573
AN - SCOPUS:84865065666
VL - 21
SP - 3926
EP - 3939
JO - Human Molecular Genetics
JF - Human Molecular Genetics
SN - 0964-6906
IS - 17
M1 - dds159
ER -